Primary outcome is the change in depressive symptoms measured by the PHQ-9 ; secondary outcomes include response , remission and relapse , functional quality of life ( SF-12 and EQ-5D-3 L ) , other clinical and psychosocial variables , direct and indirect costs , and the incremental cost-effectiveness ratio .